132 related articles for article (PubMed ID: 34977531)
1. Laboratory biosafety measures of SARS-CoV-2 at containment level 2 with particular reference to its more infective variants.
Naeem W; Zeb H; Rashid MI
Biosaf Health; 2022 Feb; 4(1):11-14. PubMed ID: 34977531
[TBL] [Abstract][Full Text] [Related]
2. Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.
Wang K; Zhu X; Xu J
Health Secur; 2020; 18(3):232-236. PubMed ID: 32522074
[TBL] [Abstract][Full Text] [Related]
3. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent.
Kaufer AM; Theis T; Lau KA; Gray JL; Rawlinson WD
Pathology; 2020 Dec; 52(7):790-795. PubMed ID: 33070960
[TBL] [Abstract][Full Text] [Related]
4. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis.
Mourya DT; Sapkal G; Yadav PD; M Belani SK; Shete A; Gupta N
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):172-176. PubMed ID: 32242878
[TBL] [Abstract][Full Text] [Related]
5. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
6. [Principles and suggestions on biosafety protection of biological specimen preservation during prevalence of COVID-19].
Zhang X; Sun W; Shang S; Mao J; Fu J; Shu Q; Jiang K
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(2):170-177. PubMed ID: 32391660
[TBL] [Abstract][Full Text] [Related]
7. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
Reifel KM; Swan BK; Jellison ER; Ambrozak D; Baijer J; Nguyen R; Monard S; Lyon G; Fontes B; Perfetto SP
Cytometry A; 2020 Jul; 97(7):674-680. PubMed ID: 32488957
[TBL] [Abstract][Full Text] [Related]
8. Rapid and sensitive diagnostic procedure for multiple detection of pandemic Coronaviridae family members SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV: a translational research and cooperation between the Phan Chau Trinh University in Vietnam and University of Bari "Aldo Moro" in Italy.
Pham VH; Gargiulo Isacco C; Nguyen KCD; Le SH; Tran DK; Nguyen QV; Pham HT; Aityan S; Pham ST; Cantore S; Inchingolo AM; Inchingolo AD; Dipalma G; Ballini A; Inchingolo F
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7173-7191. PubMed ID: 32633414
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.
Dashraath P; Wong JLJ; Lim MXK; Lim LM; Li S; Biswas A; Choolani M; Mattar C; Su LL
Am J Obstet Gynecol; 2020 Jun; 222(6):521-531. PubMed ID: 32217113
[TBL] [Abstract][Full Text] [Related]
10. The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-SARS-CoV-2.
Blacksell SD; Dhawan S; Kusumoto M; Le KK; Summermatter K; O'Keefe J; Kozlovac J; Almuhairi SS; Sendow I; Scheel CM; Ahumibe A; Masuku ZM; Kojima K; Harper DR; Hamilton K
Appl Biosaf; 2023 Jun; 28(2):87-95. PubMed ID: 37342515
[TBL] [Abstract][Full Text] [Related]
11. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
Lippi G; Adeli K; Ferrari M; Horvath AR; Koch D; Sethi S; Wang CB
Clin Chem Lab Med; 2020 Jun; 58(7):1053-1062. PubMed ID: 32396137
[TBL] [Abstract][Full Text] [Related]
12. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
Joseph T; Phyu S; Se-Thoe SY; Chu JJH
Methods Mol Biol; 2022; 2452():441-464. PubMed ID: 35554920
[TBL] [Abstract][Full Text] [Related]
13. Application of Biosafety Principles in Laboratory Analysis of Clinical Samples from Patients with COVID-19.
Hussain Gardezi SA; Ikram A
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S48-S51. PubMed ID: 32515375
[TBL] [Abstract][Full Text] [Related]
14. Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh.
Islam SRU; Akther T; Sultana S; Deb P; Ghosh AK; Nasif MAO; Bhuiyan AH; Jahan M; Nessa A; Munshi SU; Tabassum S
J Infect Dev Ctries; 2021 Dec; 15(12):1833-1837. PubMed ID: 35044940
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.
Gulati A; Pomeranz C; Qamar Z; Thomas S; Frisch D; George G; Summer R; DeSimone J; Sundaram B
Am J Med Sci; 2020 Jul; 360(1):5-34. PubMed ID: 32620220
[TBL] [Abstract][Full Text] [Related]
16. Biosafety and biosecurity approaches to restrain/contain and counter SARS-CoV-2/COVID-19 pandemic: a rapid-review.
Ahmad T; Haroon ; Dhama K; Sharun K; Khan FM; Ahmed I; Tiwari R; Musa TH; Khan M; Bonilla-Aldana DK; J Rodriguez-Morales A; Hui J
Turk J Biol; 2020; 44(3):132-145. PubMed ID: 32595350
[TBL] [Abstract][Full Text] [Related]
17. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
[TBL] [Abstract][Full Text] [Related]
18. The Anatomic Pathology laboratory adjustments in the era of COVID-19 pandemic: The experience of a laboratory in a Portuguese central hospital.
Lamas NJ; Esteves S; Alves JR; Costa FE; Tente D; Fonseca P; Vizcaíno JR
Ann Diagn Pathol; 2020 Oct; 48():151560. PubMed ID: 32645559
[TBL] [Abstract][Full Text] [Related]
19. Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens.
Bain W; Lee JS; Watson AM; Stitt-Fischer MS
Curr Protoc Cytom; 2020 Jun; 93(1):e77. PubMed ID: 32502333
[TBL] [Abstract][Full Text] [Related]
20. Laboratory containment of SARS virus.
Lim W; Ng KC; Tsang DN
Ann Acad Med Singap; 2006 May; 35(5):354-60. PubMed ID: 16830004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
